Lifeward (NASDAQ:LFWD) Trading Down 2.1% – What’s Next?

Lifeward Ltd. (NASDAQ:LFWD)’s stock price fell 2.1% on Thursday . The company traded as low as $0.5150 and last traded at $0.52. 139,117 shares traded hands during trading, a decline of 37% from the average session volume of 219,376 shares. The stock had previously closed at $0.5311.

Analyst Upgrades and Downgrades

A number of analysts have issued reports on the company. HC Wainwright cut their target price on Lifeward from $13.00 to $4.50 and set a “buy” rating on the stock in a research report on Tuesday, November 18th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Lifeward in a report on Thursday, January 22nd. Two research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $4.25.

Lifeward Price Performance

The company’s 50 day simple moving average is $0.62 and its 200 day simple moving average is $0.63. The firm has a market cap of $9.51 million, a price-to-earnings ratio of -0.18 and a beta of 0.16.

Institutional Investors Weigh In On Lifeward

Several large investors have recently bought and sold shares of the stock. Citadel Advisors LLC raised its position in Lifeward by 1,271.8% in the 3rd quarter. Citadel Advisors LLC now owns 214,006 shares of the company’s stock valued at $152,000 after purchasing an additional 198,406 shares in the last quarter. HRT Financial LP grew its position in shares of Lifeward by 149.7% during the fourth quarter. HRT Financial LP now owns 49,081 shares of the company’s stock worth $28,000 after buying an additional 29,423 shares in the last quarter. Finally, Jane Street Group LLC increased its stake in shares of Lifeward by 77.3% during the fourth quarter. Jane Street Group LLC now owns 68,631 shares of the company’s stock worth $40,000 after buying an additional 29,927 shares during the period. Hedge funds and other institutional investors own 26.76% of the company’s stock.

About Lifeward

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.